Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | TP53 |
Variant | G245S |
Impact List | missense |
Protein Effect | loss of function |
Gene Variant Descriptions | TP53 G245S is a hotspot mutation that lies within the DNA binding domain of the Tp53 protein (PMID: 22713868). G245S demonstrates increased proliferation, migration, and invasion through interaction with Hnrnpa2b1 and Hnrnpa1, and increased protein stability in culture (PMID: 37030635), results in a loss of wild-type Tp53 transcriptional activity, and also confers a gain of function to Tp53, resulting in enhanced Akt signaling and transformation in cell culture (PMID: 20212049, PMID: 23538418, PMID: 17417775). |
Associated Drug Resistance | |
Category Variants Paths |
TP53 mutant TP53 exon7 TP53 G245S TP53 mutant TP53 inact mut TP53 G245S |
Transcript | NM_000546.6 |
gDNA | chr17:g.7674230C>T |
cDNA | c.733G>A |
Protein | p.G245S |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_001126113.3 | chr17:g.7674230C>T | c.733G>A | p.G245S | RefSeq | GRCh38/hg38 |
NM_001126112.3 | chr17:g.7674230C>T | c.733G>A | p.G245S | RefSeq | GRCh38/hg38 |
NM_001126113.2 | chr17:g.7674230C>T | c.733G>A | p.G245S | RefSeq | GRCh38/hg38 |
NM_001407268.1 | chr17:g.7674230C>T | c.733G>A | p.G245S | RefSeq | GRCh38/hg38 |
NM_000546.6 | chr17:g.7674230C>T | c.733G>A | p.G245S | RefSeq | GRCh38/hg38 |
NM_001407264.1 | chr17:g.7674230C>T | c.733G>A | p.G245S | RefSeq | GRCh38/hg38 |
NM_001126114.3 | chr17:g.7674230C>T | c.733G>A | p.G245S | RefSeq | GRCh38/hg38 |
NM_001126112.2 | chr17:g.7674230C>T | c.733G>A | p.G245S | RefSeq | GRCh38/hg38 |
NM_001407266.1 | chr17:g.7674230C>T | c.733G>A | p.G245S | RefSeq | GRCh38/hg38 |
NM_001407270.1 | chr17:g.7674230C>T | c.733G>A | p.G245S | RefSeq | GRCh38/hg38 |
NM_001126114 | chr17:g.7674230C>T | c.733G>A | p.G245S | RefSeq | GRCh38/hg38 |
NM_001407262.1 | chr17:g.7674230C>T | c.733G>A | p.G245S | RefSeq | GRCh38/hg38 |
NM_000546 | chr17:g.7674230C>T | c.733G>A | p.G245S | RefSeq | GRCh38/hg38 |
NM_001126112 | chr17:g.7674230C>T | c.733G>A | p.G245S | RefSeq | GRCh38/hg38 |
NM_001126113 | chr17:g.7674230C>T | c.733G>A | p.G245S | RefSeq | GRCh38/hg38 |
NM_000546.5 | chr17:g.7674230C>T | c.733G>A | p.G245S | RefSeq | GRCh38/hg38 |
NM_001126114.2 | chr17:g.7674230C>T | c.733G>A | p.G245S | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|---|---|---|---|---|---|---|
TP53 G245S | lung non-small cell carcinoma | sensitive | SLMP53-2 | Preclinical - Cell culture | Actionable | In a preclinical study, SLMP53-2 inhibited growth of a non-small cell lung carcinoma cell line expressing TP53 G245S in culture (PMID: 31405179). | 31405179 |